Biocatalysis: the next molecular biology revolution
02 June, 2004 by Susan WilliamsonThe biocatalysis group at CSIRO Molecular Science, led by Prof Michael Zachariou, has established an impressive pipeline of research and is working towards developing a more sustainable and renewable chemical industry in Australia, writes Susan Williamson.
Beam me up: the Synchotron is on its way
27 May, 2004 by Melissa TrudingerMedical researchers in Melbourne were given a brief glimpse this week of the potential of the synchrotron to enhance and expand medical science.
Renowned polymer chemist to join Bio21
10 May, 2004 by Melissa TrudingerExpatriate Australian polymer chemist Prof Andrew Holmes is set to join Melbourne's Bio21 Institute of Molecular Science and Biotechnology in October.
Stem Cell Centre relieved by fed funding top-up
10 May, 2004 by Melissa TrudingerThe National Stem Cell Centre has received a substantial boost in the form of an extra AUD$55 million in federal government funding to support it through the period 2006-2011.
Further studies planned into J&J and Amgen anaemia drug risks
05 May, 2004 by ReutersA US advisory panel has voiced support for further research to determine whether widely used anaemia drugs sold by Johnson & Johnson and Amgen might stimulate tumour growth.
Singapore's Cordlife sets up CyGenics, plans Australian capital raising
23 April, 2004 by Renate KrelleSingapore-based Cordlife has created a holding company, CyGenics, which will be based in Melbourne, and revealed plans to raise up to $20 million in funding.
Select Vaccines aiming to raise $1.8m
20 April, 2004 by Melissa TrudingerSelect Vaccines (ASX:SLT) is planning to raise up to AUD$1.8 million in a private placement to support its R&D programs.
Long journey, but Living Cell Technologies finally nears market
20 April, 2004 by Melissa TrudingerCell therapy company Living Cell Technologies (LCT) is planning to list on the ASX in the next few months, after completing a rights issue which will provide it with AUD$4.8 million cash and the ability to upgrade from its current listing on the Newcastle Stock Exchange (NSX:LCT).
Stem Cell Sciences relocates to Scotland
19 April, 2004 by Graeme O'NeillSome tartan-clad angels -- and a need to be closer to European customers -- are behind a decision by Melbourne-born company Stem Cell Sciences to relocate its headquarters to Edinburgh.
Psivida earns new European patent
15 March, 2004 by Graeme O'NeillPerth-based biotech-nanotech company pSivida (ASX:PSD) announced today that its UK subsidiary PsiMedica has been granted the latest in a series of European patents on its proprietary biocompatible-biodegradable silicon technology, BioSilicon.
Stem cell research offers hope for baldness cure
15 March, 2004 by Staff WritersHair follicles may carry a special type of cell that has the potential to grow into various types of tissue, a finding that could lead scientists closer to a cure for baldness, according to US dermatologists.
First patent granted to Norwood Immunology
17 February, 2004 by Melissa TrudingerNorwood Abbey (ASX:NAL) subsidiary Norwood Immunology has been granted its first patent, covering the use of GnRH analogues to increase the T cell population for the treatment of a variety of diseases.
Lorne Protein report: the secrets of VII tripeptide
13 February, 2004 by Graeme O'NeillIn Douglas Adams' A Hitchhiker's Guide to the Galaxy, humans learned that the answer to the question of "life, the universe and everything" is 42. The late author would no doubt have been amused to learn that 7 and 6, the factors of 42, provide an insight into the mysteries of death, from lethal brain disorders like Alzheimer's and Parkinson's disease.
Prion-like protein may be involved in memory
29 January, 2004 by Melissa TrudingerPrion-like proteins may hold the key to understanding how the brain forms lasting memories, according to the Nobel prize-winning researcher from Columbia University Prof Eric Kandel, who is in Australia for the Australian Neuroscience Society conference in Melbourne this week.
Synchrotron gets $15m for beamlines
27 January, 2004 by Melissa TrudingerThe University of Melbourne, Monash University and the CSIRO have joined forces to provide AUD$15 million towards the initial beamlines planned for the Australian Synchrotron project, currently under construction at Monash University.
